4.8 Article

CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

CD4+ T cells in cancer

Daniel. E. Speiser et al.

Summary: Speiser and colleagues provide an overview of recent advances in understanding the biological roles of CD4(+) T cells in cancer immunology and their applications in immunotherapy. While most research in oncology has focused on CD8(+) T cells and the tumor microenvironment, recent progress has highlighted the importance of CD4(+) T cells as central players in innate and antigen-specific immune responses. Furthermore, they have been recognized as potent anti-tumor effector cells. This review summarizes the current state of CD4(+) T cells in cancer and their potential for improving cancer knowledge and therapies.

NATURE CANCER (2023)

Article Immunology

Interferon-g primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway

Daniel S. Simpson et al.

Summary: Cell death is crucial in pathogen infections. IFNg sensitizes macrophages to TLR-induced death by triggering macrophage-intrinsic death ligands and caspase-8 enzymatic activity. This process requires BAX and BAK, the mitochondrial apoptotic effectors.

IMMUNITY (2022)

Article Multidisciplinary Sciences

Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells

J. Joseph Melenhorst et al.

Summary: CAR T cells redirected to target CD19 demonstrated long-lasting potential and clonal stability in two patients with chronic lymphocytic leukaemia. Highly activated CD4(+) cells emerged and dominated the CAR T cell population at later time points. These unexpected CAR T cell populations provide novel insights into anti-cancer response and long-term remission in leukaemia.

NATURE (2022)

Article Oncology

Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function

Joshua R. Veatch et al.

Summary: This study utilized single-cell RNA sequencing to investigate tumor-specific CD4(+) T cells infiltrating human melanoma and identified their phenotypes and functions. The expression of these tumor-specific CD4(+) T cells in the tumor microenvironment correlated with the transcriptional states of CD8(+) T cells and macrophages, maturation of B cells, and patient survival.

CANCER CELL (2022)

Article Multidisciplinary Sciences

Landscape of helper and regulatory antitumour CD4+ T cells in melanoma

Giacomo Oliveira et al.

Summary: In this study, the phenotype and tumor specificity of CD4 (+) T cells infiltrating human melanoma specimens were analyzed in depth, revealing that melanoma cells can directly induce exhausted cytotoxic CD4 (+) T cells through recognition of HLA class II-restricted neoantigens and HLA class I-restricted tumor-associated antigens. CD4 (+) T regulatory (T-Reg) cells can be indirectly elicited through the presentation of tumor antigens via antigen-presenting cells. Interestingly, a large number of tumor-reactive CD4 (+) T-Reg clones were stimulated directly by HLA class II-positive melanoma and showed specificity for melanoma neoantigens. These findings suggest that the presentation of HLA class II-restricted neoantigens and direct engagement of immunosuppressive CD4 (+) T-Reg cells are favored mechanisms of immune evasion in HLA class II-positive melanoma.

NATURE (2022)

Article Multidisciplinary Sciences

A vaccine targeting resistant tumours by dual T cell plus NK cell attack

Soumya Badrinath et al.

Summary: A cancer vaccine that induces a coordinated attack by diverse T cell and NK cell populations is reported. The vaccine targets MICA/B stress proteins expressed by human cancers and enhances immune recognition by inhibiting proteolytic shedding, increasing antigen presentation, and augmenting cytotoxic function. The vaccine also shows efficacy in inhibiting metastasis and protecting against escape mutations.

NATURE (2022)

Article Oncology

Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell-Cell Interactions That Predict Immunotherapy Response

Asier Antoranz et al.

Summary: This study uses multiplexed IHC to spatially characterize the immune landscape of metastatic melanoma from responders and nonresponders to immune checkpoint-based immunotherapy (ICI). The results show that T cells gradually evolve towards an exhausted phenotype as they approach and infiltrate the tumor, and a key cellular interaction network is functionally linked with PD-L1(+) macrophages. Mapping the respective spatial distributions of these two cell populations predicts response to anti-PD-1 immunotherapy with high confidence.

CANCER RESEARCH (2022)

Review Immunology

Dendritic Cells Revisited

Mar Cabeza-Cabrerizo et al.

Summary: Dendritic cells play a crucial role in shaping adaptive and innate immunity by integrating environmental information. Conventional DCs, a discrete cell lineage, are highlighted in this review for their key features and impact on other leukocytes.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)

Article Biochemistry & Molecular Biology

Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes

Rajendra Karki et al.

Summary: The combination of TNF-alpha and IFN-gamma induces inflammatory cell death characterized by PANoptosis, which can be inhibited to protect mice from the pathological effects and death caused by COVID-19. Blocking the cytokine-mediated inflammatory cell death signaling pathway may benefit patients with COVID-19 or other infectious and autoinflammatory diseases by limiting tissue damage/inflammation.
Review Immunology

Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation

Karthik Dhatchinamoorthy et al.

Summary: Loss of MHC I antigen presentation is common in many cancers, which may impair immune responses and affect the efficacy of immunotherapy. Studies have discussed underlying mechanisms through which some cancers evade immune killing by shutting down the MHC I pathway, and proposed potential strategies to overcome this limitation.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma

Antoni Ribas et al.

Summary: In patients with advanced melanoma, combining intratumoral TLR9 agonist vidutolimod with pembrolizumab showed promising clinical activity and manageable safety profile, indicating potential to overcome resistance to PD-1 blockade through IFN response induction.

CANCER DISCOVERY (2021)

Article Oncology

Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma

Lisa Haas et al.

Summary: The study reveals that tumors relapsing after targeted therapy show cross-resistance to immunotherapies due to an immunosuppressive tumor microenvironment lacking CD103(+) dendritic cells. Cross-resistance is not a result of immune response pressure during resistance evolution, but stems from the MAPK pathway's increased transcriptional output driving immune evasion. Restoring CD103(+) dendritic cells can resensitize tumors to immunotherapy.

NATURE CANCER (2021)

Article Biochemistry & Molecular Biology

Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer

David Y. Oh et al.

Article Biochemistry & Molecular Biology

Solo: Doublet Identification in Single-Cell RNA-Seq via Semi-Supervised Deep Learning

Nicholas J. Bernstein et al.

CELL SYSTEMS (2020)

Article Multidisciplinary Sciences

cDC1 prime and are licensed by CD4+T cells to induce anti-tumour immunity

Stephen T. Ferris et al.

NATURE (2020)

Article Biotechnology & Applied Microbiology

Generalizing RNA velocity to transient cell states through dynamical modeling

Volker Bergen et al.

NATURE BIOTECHNOLOGY (2020)

Review Immunology

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Alex D. Waldman et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity

Mikhail Binnewies et al.

Article Pathology

Diversity, Mechanisms, and Significance of Macrophage Plasticity

Massimo Locati et al.

Annual Review of Pathology-Mechanisms of Disease (2019)

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

Review Immunology

Developmental and Functional Heterogeneity of Monocytes

Martin Guilliams et al.

IMMUNITY (2018)

Review Immunology

CD4+ T cell help in cancer immunology and immunotherapy

Jannie Borst et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Article Biotechnology & Applied Microbiology

SCANPY: large-scale single-cell gene expression data analysis

F. Alexander Wolf et al.

GENOME BIOLOGY (2018)

Article Cell Biology

Multiplex Staining by Sequential Immunostaining and Antibody Removal on Routine Tissue Sections

Maddalena Maria Bolognesi et al.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2017)

Review Multidisciplinary Sciences

Elements of cancer immunity and the cancer-immune set point

Daniel S. Chen et al.

NATURE (2017)

Article Biochemical Research Methods

SCENIC: single-cell regulatory network inference and clustering

Sara Aibar et al.

NATURE METHODS (2017)

Article Biochemistry & Molecular Biology

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

Nicholas McGranahan et al.

Article Microscopy

Flat field correction for high-throughput imaging of fluorescent samples

Peet Kask et al.

JOURNAL OF MICROSCOPY (2016)

Review Multidisciplinary Sciences

Adoptive cell transfer as personalized immunotherapy for human cancer

Steven A. Rosenberg et al.

SCIENCE (2015)

Article Biochemistry & Molecular Biology

Out Knocker: a web tool for rapid and simple genotyping of designer nuclease edited cell lines

Jonathan L. Schmid-Burgk et al.

GENOME RESEARCH (2014)

Article Medicine, Research & Experimental

Collective nitric oxide production provides tissue-wide immunity during Leishmania infection

Romain Olekhnovitch et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Multidisciplinary Sciences

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Paul C. Tumeh et al.

NATURE (2014)

Article Multidisciplinary Sciences

T-helper-1-cell cytokines drive cancer into senescence

Heidi Braumueller et al.

NATURE (2013)

Article Multidisciplinary Sciences

Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

Jennifer Landsberg et al.

NATURE (2012)

Article Medicine, General & Internal

Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1

Naomi N. Hunder et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Immunology

Primary antitumor immune response mediated by CD4+ T cells

A Corthay et al.

IMMUNITY (2005)

Article Immunology

Visualizing dendritic cell networks in vivo

RL Lindquist et al.

NATURE IMMUNOLOGY (2004)